Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Bullboard (GREY:ATBPF)

View:
Prev ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... Next
Post by Stutterson Jul 29, 2022 11:17am

Have a great long weekend everyone

Pez, Sandbox and MarkyMarx, peace out
61
Post by Stutterson Jul 29, 2022 11:02am

Does this sound like Mugsy works for Ate???

@MUGMODs Not sure what you are saying with the list but ... clinical studies are done - commercial study is underway and I'm estimating double peak sales (from what we saw with chronic - just my ...more  
146
Post by Stutterson Jul 29, 2022 10:33am

Its hard to buy

Mugsy has been buying everything in site since $5.00
110
Post by Duster340on Jul 29, 2022 10:02am

I have not bought

but prety sure you would get filed @59
54
Post by MrMugsyon Jul 29, 2022 9:34am

Let's drop a bid of 58

and see if anyone drops their shares here.
114
Discussion
Post by Duster340on Jul 28, 2022 10:53pm

Any Buyers

tomorrow morning or is 57 cents overpaying?
136
Post by Stutterson Jul 28, 2022 8:01pm

Do the opposite of Mugsy and you will be fine!!!!!!!!!!!!!!!

Mugsy, at your dinner tonight ...be sure to grab the tab for John.  Rumour is, he is saving his coppers. Night everyone. Hey Pez  :-0
76
Post by 123ABCon Jul 28, 2022 4:33pm

Ouch

Mugsy, you may need to work overtime to get this bad boy up
77
Post by Duster340on Jul 27, 2022 4:03pm

OMG

the 6 day streak is done closed @59, so maybe now we start a new streak of consecutive days in the 50's
88
Comment by MrMugsyon Jul 27, 2022 2:58pm

RE:New indications IP

Correct. Looks like it is also know as ATB-344 or an H2S releasing Indomethacin product. ATB-344 was initially intended for gout and the market size was about $500M (2013). For the past 2 years we ...more  
181
Discussion
Post by Daydream2on Jul 27, 2022 12:50pm

New indications IP

No mention of this on page 22 on the latest presentation?  https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022115952
169
Discussion
Post by Duster340on Jul 27, 2022 10:54am

will today be the 7th straight day of a 60 or 61

cent close,  i say yes and not only will get to 7 days, i predict we will see over 10 days in a row.
63
Prev ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities